Neurochemistry of the nucleus accumbens and its relevance to depression and antidepressant action in rodents

Current Neuropharmacology

Volumn 4, Issue 4, 2006, Pages 277-291

  Shirayama, Yukihiko ^a,c   Chaki, Shigeyuki ^b  

^a TOTTORI UNIVERSITY   (Japan)

^b TAISHO PHARMACEUTICAL CO LTD   (Japan)

^c CHIBA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

aminobutyric acid (GABA); Acetylcholine; cAMP response element binding protein (CREB); Depression; Dopamine; Dynorphin; Glutamate; Nucleus accumbens

Indexed keywords

2 AMINO 5 PHOSPHONOVALERIC ACID; 4 AMINOBUTYRIC ACID; ACETYLCHOLINE; AMPA RECEPTOR; AMPHETAMINE; ANTIDEPRESSANT AGENT; BRAIN DERIVED NEUROTROPHIC FACTOR; COCAINE AND AMPHETAMINE REGULATED TRANSCRIPT PEPTIDE; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; DIZOCILPINE; DOPAMINE; DOPAMINE RECEPTOR; DOPAMINE RECEPTOR STIMULATING AGENT; DOPAMINE UPTAKE INHIBITOR; DYNORPHIN; ENKEPHALIN; FLUOXETINE; GLUTAMATE RECEPTOR; GLUTAMIC ACID; IMIPRAMINE; KETAMINE; MELANIN CONCENTRATING HORMONE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; NEUROPEPTIDE; NEUROTRANSMITTER; PHENCYCLIDINE; PRAMIPEXOLE; SEROTONIN; SEROTONIN UPTAKE INHIBITOR; UNINDEXED DRUG;

ANHEDONIA; BRAIN DYSFUNCTION; BRAIN REGION; DEPRESSION; DOPAMINERGIC ACTIVITY; DRUG BINDING SITE; DRUG EXPOSURE; DRUG RECEPTOR BINDING; DRUG WITHDRAWAL; LEARNING; NEUROCHEMISTRY; NEUROPATHOLOGY; NONHUMAN; NUCLEUS ACCUMBENS; PHENOTYPE; PROTEIN SYNTHESIS INHIBITION; REVIEW; RODENT; STRESS;

EID: 33749512952     PISSN: 1570159X     EISSN: None     Source Type: Journal    
DOI: 10.2174/157015906778520773     Document Type: Review

References (181)

1. Adams, B., Moghaddam, B. (1998) Corticolimbic dopamine neurotransmission is temporally dissociated from the cognitive and locomotor effects of phencyclidine. J. Neurosci., 18, 5545-5554.
2. Ainsworth, K., Smith, S.E., Zetterstrom, T.S., Pei, Q., Franklin, M., Sharp, T. (1998) Effect of antidepressant drugs on dopamine D1 and D2 receptor expression and dopamine release in the nucleus accumbens of the rat. Psychopharmacology, 140, 470-477.
3. B receptors in the nucleus accumbens shell differentially modulate dopamine and acetylcholine receptor-mediated turning behaviour. Neuropharmacology, 46, 1082-1088.
4. Altamura, C.A. , Mauri, M. C., Ferrara, A., Moro, A. R., D'Andrea, G., Zamberlan, F. (1993) Plasma and platelet excitatory amino acids in psychiatry disorders. Am. J. Psychiatry, 150, 1731-1733.
5. American Psychiatric Association. (1994) Diagnostic and Statistical Manual of Mental Disorders, 4th Edition. Washington DC, American Psychiatric Press.
6. Bals-Kubik, R., Ableitner, A., Herz, A., Shippenberg, T.S. (1993) Neuroanatomical sites mediating the motivational effects of opioids as mapped by the conditioned place preference paradigm in rats. J. Pharmacol. Exp. Ther., 264, 489-495.
7. Bannon, A. W., Seda , J., Carmouche, M., Francis, J. M., Jarosinski, M.A., Douglass, J. (2001) Multiple behavioral effects of cocaine- and amphetamine-regulated transcript (CART) peptides in mice: CART 42-89 and CART 49-89 differ in potency and activity. J. Pharmacol. Exp. Ther., 299, 1021-1026.
8. Barr, A.M., Markou, A., Phillips, A.G. (2002) A 'crash' course on psychostimulant withdrawal as a model of depression. Trends Pharmacol Sci., 23, 475-482.
9. Barr, A.M., Phillips, A.G. (1999) Withdrawal following repeated exposure to d-amphetamine decreases responding for a sucrose solution as measured by a progressive ratio schedule of reinforcement. Psychopharmacolqgy, 141, 99-106.
10. Barrot, M., Olivier, J.D., Perrotti, L.I., DiLeone, R.J., Berton, O., Eisch, A.J., Impey, S., Storm, D.R., Neve, R.L., Yin, J.C., Zachariou, V., Nestler, E.J. (2002) CREB activity in the nucleus accumbens shell controls gating of behavioral responses to emotional stimuli. Proc. Natl. Acad. Sci. USA, 99, 11435-11440.
11. Bassareo, V., De Luca MA., Di Chiara, G. (2002) Differential expression of motivational stimulus properties by dopamine in nucleus accumbens shell versus core and prefrontal cortex. J. Neurosci., 22, 4709-4719.
12. Basso, A.M., Gallagher, K.B., Bratcher, N.A., Brioni, J.D., Moreland, R.B., Hsieh, G.C., Drescher, K., Fox, G.B., Decker, M.W., Rueter, L.E. (2005) Antidepressant-Like Effect of D(2/3) Receptor-, but not D(4) Receptor-Activation in the Rat Forced Swim Test. Neuropsychopharmacology, 30, 1257-1268.
13. Beitner-Johnson, D., Nestler, E.J. (1991) Morphine and cocaine exert common chronic actions on tyrosine hydroxylase in dopaminergic brain reward regions. J. Neurochem., 57, 344-347.
14. Berman, R.M., Cappiello, A., Anand, A., Oren, D.A., Heninger, G.R., Charney, D.S., Krystal, J.H. (2000) Antidepressant effects of ketamine in depressed patients. Biol. Psychiatry, 47, 351-354.
15. Bertrand, E., Smadja, C., Mauborgne, A., Roques, B.P., Dauge, V. (1997) Social interaction increases the extracellular levels of [Met]enkephalin in the nucleus accumbens of control but not of chronic mild stressed rats. Neuroscience, 80, 17-20.
16. Bittencourt, J.C., Presse, F., Arias, C., Peto, C., Vaughan, J., Nahon, J.L., Vale, W., Sawchenko, P.E. (1992) The melanin-concentrating hormone system of the rat brain: an immuno- and hybridization histochemical characterization. J. Comp. Neurol., 319, 218-245.
17. Borowsky, B., Durkin, M.M., Ogozalek, K., Marzabadi, M.R., DeLeon, J., Lagu, B., Heurich, R., Lichtblau, H., Shaposhnik, Z., Daniewska, I., Blackburn, T.P., Branchek, T.A., Gerald, C., Vaysse, P.J., Forray, C. (2002) Antidepressant, anxiolytic and anorectic effects of a melanin-concentrating hormone-1 receptor antagonist. Nat. Med, 8, 825-830.
18. Borsini, F., Mancinelli, A., D'Aranno, V., Evangelista, S., Meli, A. (1988) On the role of endogenous GABA in the forced swimming test in rats. Pharmacol. Biochem. Behav., 29, 275-279.
19. Brambilla, P., Perez, J., Barale, F., Schettini, G., Soares, J.C. (2003) GABAergic dysfunction in mood disorders. Mol. Psychiatry, 8, 721-737.
20. Breiter, H.C., Gollub, R.L., Weisskoff, R.M., Kennedy, D.N., Makris, N., Berke, J.D., Goodman, J.M., Kantor, H.L., Gastfriend, D.R., Riorden, J.P., Mathew, R.T., Rosen, B.R., Hyman, S.E. (1997) Acute effects of cocaine on human brain activity and emotion. Neuron, 19, 591-611.
21. Broom, D.C., Jutkiewicz, E.M., Folk, J.E., Traynor, J.R., Rice, K.C., Woods, J.H. (2002) Nonpeptidic delta-opioid receptor agonists reduce immobility in the forced swim assay in rats. Neuropsychopharmacology, 26, 744-755.
22. Cabib, S., Puglisi-Allegra, S. (1994) Opposite responses of mesolimbic dopamine system to controllable and uncontrollable aversive experiences. J. Neurosci., 14, 3333-3340.
23. Campbell, A.D., McBride, W.J. (1995) Serotonin-3 receptor and ethanol-stimulated dopamine release in the nucleus accumbens. Pharmacol. Biochem. Behav., 51, 835-842.
24. Cardinal, R.N., Cheung, T.H.C. (2005) Nucleus accumbens core lesions retard instrumental learning and performance with delayed reinforcement in the rat BMC Neurosci., 6, 9.
25. Carlezon, W.A. Jr., Thome, J., Olson, V.G., Lane-Ladd, S.B., Brodkin, E.S., Hiroi, N., Duman, R.S., Neve, R.L., Nestler, E.J. (1998) Regulation of cocaine reward by CREB. Science, 282, 2272-2275.
26. Carlezon, W.A. Jr., Wise, R.A. (1996) Rewarding actions of phencyclidine and related drugs in nucleus accumbens shell and frontal cortex. J. Neurosci., 16, 3112-3122.
27. Chaki, S., Funakoshi, T., Hirota-Okuno, S., Nishiguchi, M:, Shimazaki, T., Iijima, M., Grottick, A.J., Kanuma, K., Omodera, K., Sekiguchi, Y., Okuyama, S., Tran, T.A., Semple, G., Thomsen, W. (2005) Anxiolytic- and antidepressant-like profile of ATC0065 and ATC0175: Nonpeptidic and orally active melanin-concentrating hormone receptor 1 antagonists. J. Pharmacol. Exp. Ther., 313, 831-839.
28. Chaki, S., Yoshikawa, R., Hirota, S., Shimazaki, T., Maeda, M., Kawashima, N., Yoshimizu, T., Yasuhara, A., Sakagami, K., Okuyama, S., Nakanishi, S., Nakazato, A. (2004) MGS0039: a potent and selective group II metabotropic glutamate receptor antagonist with antidepressant-like activity. Neuropharmacology, 46, 457-467.
29. Chang, H.T., Kitai, S.T. (1985) Projection neurons of the nucleus accumbens: an intracellular labeling study. Brain Res., 347, 112-116.
30. Chau, D.T., Rada, P., Kosloff, R.A., Taylor, J.L., Hoebel, B.G. (2001) Nucleus accumbens muscarinic receptors in the control of behavioral depression antidepressant like effect of local M1 antagonist in the Porsolt swim test. Neuroscience, 104, 791-798.
31. Collins, S.L., Kunko, P.M., Ladenheim, B., Cadet, J.L., Carroll, F.I., Izenwasser, S. (2002) Chronic cocaine increases kappa-opioid receptor density: lack of effect by selective dopamine uptake inhibitors. Synapse, 45, 153-158.
32. Connor, T.J., Song, C., Leonard, B.E., Anisman, H., Merali, Z. (1999) Stressor-induced alterations in serotonergic activity in an animal model of depression. Neuroreport. 10, 523-528.
33. Cryan, J.F., Kelly, P.H., Neijt, H.C., Sansig, G., Flor, P.J., van Der Putten, H. (2003) Antidepressant and anxiolytic-like effects in mice lacking the group III metabotropic glutamate receptor mGluR7. Eur. J. Neurosci., 17, 2409-2417.
34. De Felipe, M.C., De Ceballos, M.L., Gil, C., Fuentes, J.A. (1985) Chronic antidepressant treatment increases enkephalin levels in n. accumbens and striatum of the rat. Eur. J. Pharmacol., 112, 119-122.
35. De La Garza II, R., Mahoney III, J.J. (2004) A distinct neurochemical profile in WKY rats at baseline and in response to acute stress: Implications for animal models of anxiety and depression. Brain Res., 1021, 209-218.
36. De La Garza II, R., Jentsch, J.D., Verrico, C.D., Roth, R.H. (2002) Adaptation of monoaminergic responses to phencyclidine in nucleus accumbens and prefrontal cortex following repeated treatment with fluoxetine or imipramine. Brain Res., 958, 20-27.
37. Di Chiara, G., Loddo, P., Tanda, G. (1999) Reciprocal changes in prefrontal and limblic dopamine responsiveness to aversive and rewarding stimuli after chronic mild stress: implications for the psychobiology of depression. Biol. Psychiatry, 46, 1624-1633.
38. Di Chiara, G., Tanda, G. (1997) Blunting of reactivity of dopamine transmission to palatable food: a biochemical marker of anhedonia in the CMS model? Psychopharmacology, 134, 351-353.
39. Dilsaver, S.C. (1986) Cholinergic mechanisms in depression. Brain Res., 396, 285-316.
40. Di Matteo, V., De Blasi, A., Di Giulio, C., Esposito, E. (2001) Role of 5-HT(2C) receptors in the control of central dopamine function. Trends Pharmacol. Sci., 22, 229-232.
41. Douglass, J., McKinzie, A.A., Couceyro, P. (1995) PCR differential display identifies a rat brain mRNA that is transcriptionally regulated by cocaine and amphetamine. J. Neurosci., 15, 2471-2481.
42. Dremencov, E., Newman, M.E., Kinor, N., Blatman-Jan, G., Schindler, C.J., Overstreet, D.H., Yadid, G. (2005) Hyperfunctionality of serotonin-2C receptor-mediated inhibition of accumbal dopamine release in an animal model of depression is reversed by antidepressant treatment. Neuropharmacology, 48, 34-42.
43. Dziedzicka-Wasylewska, M., Papp, M. (1996) Effect of chronic mild stress and prolonged treatment with imipramine on the levels of endogenous Met-enkephalin in the rat dopaminergic mesolimbic system. Pol. J. Pharmacol., 48, 53-6.
44. Dziedzicka-Wasylewska, M., Willner, P., Papp, M. (1997) Changes in dopamine receptor mRNA expression following chronic mild stress and chronic antidepressant treatment. Behav. Pharmacol., 8, 607-618.
45. Eisch, A.J., Bolanos, C.A., de Wit, J., Simonak, R.D., Pudiak, C.M., Barrot, M., Verhaagen, J., Nestter, E.J. (2003) Brain-derived neurotrophic factor in the ventral midbrain-nucleus accumbens pathway: a role in depression. Biol. Psychiatry, 54, 994-1005.
46. Ernst, M., Nelson, E.E., McClure, E.B., Monk, C.S., Munson, S., Eshel, N., Zarahn, E., Leibenluft, E., Zametkin, A., Towbin, K., Blair, J., Charney, D., Pine, D.S. (2004) Choice selection and reward anticipation: an fMRI study. Neuropsychologia, 42, 1585-1597.
47. Fadda, P., Scherma, M., Fresu, A., Collu, M., Fratta, W. (2003) Baclofen antagonizes nicotine-, cocaine-, and morphine-induced dopamine release in the nucleus accumbens of rat Synapse, 50, 1-6.
48. Ferguson, S.M., Brodkin, J.D., Lloyd, G.K., Menzaghi, F. (2000) Antidepressant-like effects of the subtype-selective nicotinic acetylcholine receptor agonist, SIB-1508Y, in the learned helplessness rat model of depression. Psychopharmacology, 152, 295-303.
49. Ferretti, V., Florian, C., Costantini, V.J.A., Roullet, P., Rinaldi, A., De Leonibus, E., Oliverio, A., Mele, A. (2005) Co-activation of glutamate and dopamine receptors within the neucleus accumbens is required for spatial memory consolidation in mice. Psychopharmacology, 179, 108-116.
50. Filliol, D., Ghozland, S., Chluba, J., Martin, M., Matthes, H.W., Simonin, F. Befort K. Gaverian-Ruff, C., Dierich A. LeMeur, M., Valverde, O., Maldonado, R., Kieffer, B.L. (2000) Mice deficient for delta- and mu-opioid receptors exhibit opposing alterations of emotional responses. Nature Genet., 25, 195-200.
51. Fryer, J.D., Lukas, R.L. (1999) Antidepressants noncompetitively inhibit nicotinic acetylcholine receptor function. J. Neurochem., 72, 1117-1124.
52. Fusa, K., Takahashi, I., Watanabe, S., Aono, Y., Ikeda, H., Saigusa, T., Nagase. H., Suzuki, T., Koshikawa. N.. Cools. A.R. (2005) The non-peptidic delta opioid receptor agonist TAN-67 enhances dopamine efflux in the nucleus accumbens of freely moving rats via a mechanism that involves both glutamate and free radicals. Neuroscience, 130, 745-755.
53. Gambarana, C., Masi, F., Tagliamonte, A., Scheggi, S., Ghiglieri, O., De Montis, M.G. (1999) A chronic stress that impairs reactivity in rats also decreases dopaminergic transmission in the nucleus accumbens: a microdialysis study. J. Neurochem., 72, 2039-2046.
54. Garattini, S. (1997) Pharmacology of amineptine, an antidepressant agent acting on the dopaminergic system: a review. Int. Clin. Psychopharmacol., 12 (Suppl 3), S15-S19.
55. Georgescu, D., Sears, R.M., Hommel, J.D., Barrot, M., Bolanos, C.A., Marsh, D.J., Bednarek, MA., Bibb, J.A., Maratos-Flier, E., Nestler, E.J., DiLeone, R.J. (2005) The hypothalamic neuropeptide melanin-concentrating hormone acts in the nucleus accumbens to modulate feeding behavior and forced-swim performance. J. Neurosci., 25, 2933-2940.
56. Gibson, W.T., Pissios, P., Trombly, D.J., Luan, J., Keogh, J., Wareham, N.J., Maratos-Flier, E., O'Rahilly, S., Farooqi, I.S. (2004) Melanin-concentrating hormone receptor mutations and human obesity: functional analysis. Obes. Res., 12, 743-749.
57. Giertler, C., Bohn, I., Hauber, W. (2005) Involvement of NMDA and AMPA/ KA receptors in the nucleus accumbens core in instrumental learning guided by reward-predictive cues. Eur. J. Neurosci., 21, 1689-1702.
58. Grimm, J.W., Lu, L., Hayashi, T., Hope, B.T., Su, T.P., Shaham, Y. (2003) Time-dependent increases in brain-derived neurotrophic factor protein levels within the mesolimbic dopamine system after withdrawal from cocaine: implications for incubation of cocaine craving. J. Neurosci., 23, 742-747.
59. Harrison, A.A., Liem, Y.T., Markou, A. (2001) Fluoxetine combined with a serotonin-1A receptor antagonist reversed reward deficits observed during nicotine and amphetamine withdrawal in rats. Neuropsychopharmacology, 25, 55-71.
60. Hennings, E.C., Kiss, J.P., Vizi, E.S. (1997) Nicotinic acetylcholine receptor antagonist effect of fluoxetine in rat hippocampal slices. Brain Res., 759, 292-294.
61. Hervieu, G.J., Cluderay, J.E., Harrison, D., Meakin J., Maycox, P., Nasir, S., Leslie, R.A. (2000) The distribution of the mRNA and protein products of the melanin-concentrating hormone (MCH) receptor gene, slc- 1, in the central nervous system of the rat. Eur. J. Neurosci., 12, 1194-1216.
62. Herz, A. (1997) Endogenous opioid systems and alcohol addiction. Psychopharmacology, 129, 99-111.
63. Hikida, T., Kitabatake, Y., Pastan, I., Nakanishi, S. (2003) Acetylcholine enhancement in the nucleus accumbens prevents addictive behaviors of cocaine and morphine. Proc. Natl. Acad. Sci. USA, 100, 6169-6173.
64. Hjelmstad, G.O. (2004) Dopamine excites nucleus accumbens neurons through the differential modulation of glutamate and GABA release. J. Neurosci., 24, 8621-8628.
65. Hjelmstad, G.O., Fields, H.L. (2001) Kappa opioid receptor inhibition of glutamatergic transmission in the nucleus accumbens shell. J. Neurophysiol., 85, 1153-1158.
66. Hong, J.S., Gillin, J.C., Yang, H.Y., Costa, E. (1979) Repeated electroconvulsive shocks and the brain content of endorphins. Brain Res., 177, 273-278.
67. Horger, BA,, Iyasere, CA., Berhow, M.T., Messer, C.J., Nestler, E.J., Taylor, J.R. (1999) Enhancement of locomotor activity and conditioned reward to cocaine by brain-derived neurotrophic factor. J. Neurosci., 19, 4110-4122.
68. Hu, G., Duffy, P., Swanson, C., Ghasemzadeh, M.B., Kalivas, P.W. (1999) The regulation of dopamine transmission by metabotropic glutamate receptors. J. Pharmacol. Exp. Ther., 289, 412-416.
69. Ichikawa, J., Kuroki, T., Meltzer, H.Y. (1998) Differential effects of chronic imipramine and flouxetine on basal and amphetamine-induced extracellular dopamine levels in rat nucleus accumbens. Eur. J. Pharmacol., 350, 159-164.
70. Ito, R., Robbins, T.W., Everitt, B.J. (2004) Differential control over cocaine-seeking behavior by nucleus accumbens core and shell. Nature Neurosci., 7, 389-397.
71. Jaworski, J.N., Kozel, M.A., Philpot, K.B., Kuhar, M.J. (2003) Intra-accumbal injection of CART (cocaine-amphetamine regulated transcript) peptide reduces cocaine-induced locomotor activity. J. Pharmacol. Exp. Ther., 307, 1038-1044.
72. Jentsch, J.D., Taylor, J.R. (1999) Impulsivity resulting from frontostriatal dysfunction in drug abuse: implications for the control ofbehavior by reward-related stimuli. Psychopharmacology, 146, 373-390.
73. Kalivas, P.W., Duffy, P. (1995) Selective activation of dopamine transmission in the shell of the nucleus accumbens by stress. Brain Res., 675, 325-328.
74. Karege, F., Perret, G., Bondolfi, G., Schwald, M., Bertschy, G., Aubry, J.M. (2002) Decreased serum brain-derived neurotrophic factor levels in major depressed patients. Psychiatry Res., 109, 143-148.
75. Kawaguchi, Y., Wilson, C.J., Augood, S.J., Emson, P.C. (1995) Striatal interneurones: chemical, physiological and morphological characterization. Trends Neurosci., 18, 527-535.
76. Kelley, A.E., Smith-Roe, S.L., Holahan, M.R. (1997) Response-reinforcement learning is dependent on N-methyl-D-aspartate receptor activation in the nucleus accumbens core. Proc. Natl. Acad. Sci. USA, 94, 12174-12179.
77. Kenny, PJ., Gasparini, F., Markou, A. (2003) Group II metabotropic and alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate (AMPA)/kainate glutamate receptors regulate the deficit in brain reward function associated with nicotine withdrawal in rats. J. Pharmacol. Exp. Ther., 306, 1068-1076.
78. Koob, G.F. (1992) Drugs of abuse: anatomy, pharmacology and function of reward pathways. Trends Pharmacol Sci. 13, 177-184.
79. Koob, G.F., Bloom, F.E. (1988) Cellular and molecular mechanisms of drug dependence. Science, 242, 715-723.
80. Koylu, E.O., Couceyro, P.R., Lambert, P.D., Kuhar, M.J. (1998) Cocaine- and amphetamine-regulated transcript peptide immunohistochemical localization in the rat brain. J. Comp. Neurol., 391, 115-132.
81. Kram, M.L., Kramer, G.L., Ronan, P.J., Steciuk, M., Petty, F. (2002) Dopamine receptors and learned helplessness in the rat: an autoradiographic study. Prog. Neuropsychopharmacol. Biol. Psychiatry, 26, 639-645.
82. Kristensen, P., Judge, M.E., Thim, L., Ribel, U., Christjansen, K.N., Wulff, B.S., Clausen, J.T., Jensen, P.B., Madsen, O.D., Vrang, N., Larsen, P.J., Hastrup, S. (1998) Hypothalamic CART is a new anorectic peptide regulated by leptin. Nature, 393, 72-76.
83. Krystal, J.H., Sanacora, G., Blumberg, H., Anand, A., Charney, D.S., Marek, G., Epperson, C.N., Goddard, A., Mason, G.F. (2002) Glutamate and GABA systems as targets for novel antidepressant and mood-stabilizing treatments. Mol. Psychiatry, 7, S71-S80.
84. Kurumaji A., Mitsushio H., Takashima M. (1988) Chronic dietary treatment with antidepressants decrease brain Met-enkephalin-like immunoreactivity in the rat. Psychopharmacology, 94, 188-192.
85. Kyte, Z.A., Goodyer, I.M., Sahakian, B.J. (2005) Selected executive skills in adolescents with recent first episode major depression. J. Child Psychol. Pschiat., 46, 995-1005.
86. Lammers, C.H., Diaz, J., Schwartz, J.C., Sokoloff, P. (2000) Selective increase of dopamine D3 receptor gene expression as a common effect of chronic antidepressant treatments. Mol. Psychiatry, 5, 378-388.
87. Levine, J., Panchalingam, K., Rapoport, A., Gershon, S., McClure, R.J., Pettegrew, J.W. (2000) Increased cerebrospinal fluid glutamine levels in depressed patients. Biol. Psychiatry, 47, 586-593.
88. Li, X., Tizzano, J.P., Griffey, K., Clay, M., Lindstrom, T., Skolnick, P. (2001) Antidepressant-like actions of an AMPA receptor potentiator (LY392098). Neuropharmacology, 40, 1028-1033.
89. Maes, M., Verkert, R., Vandoolaeghe, E., Lin, A., Scharpe, S. (1998) Serum levels of excitatory amino acids, serine, glycine, histidine, threonine, taurine, alanine and arginine in treatment-resistant depression: modulation by treatment with antidepressants and prediction of clinical responsivity. Acta Psychiat. Scand., 97, 302-308.
90. Mague, S.D., Pliakas, A.M., Todtenkopf, M.S., Tomasiewicz, H.C., Zhang, Y., Stevens, W.C. Jr, Jones, R.M., Portoghese, P.S., Carlezon, W.A. Jr. (2003) Antidepressant-like effects of kappa-opioid receptor antagonists in the forced swim test in rats. J. Pharmacol. Exp. Ther., 305, 323-330.
91. Maisonneuve, I.M,, Archer, S., Glick, S.D. (1994) U50,488, a kappa opioid receptor agonist, attenuates cocaine-induced increases in extracellular dopamine in the nucleus accumbens of rats. Neurosci. Lett.. 181, 57-60.
92. Maldonado-Irizarry, C.S., Kelley, A.E. (1995) Excitatory amino acid receptors within nucleus accumbens subregions differentially mediate spatial learning in the rat Behav. Pharmacol., 6, 527-539.
93. Mangiavacchi, S., Masi, F., Scheggi, S., Leggio, B., De Montis, M.G., Gambarana, B. (2001) Long-term behavioral and neurochemical effects of chronic stress exposure in rats. J. Neurochem., 79, 1113-1121.
94. Mann, J.J., McBride, P.A., Malone, K.M., DeMeo, M.D., Kelip, J.G. (1995) Blunted serotonergic, responsivity in depressed patients. Neuropsychopharmacology, 13, 53-64.
95. Marcus, M.M., Mathe, J.M., Nomikos, G.G., Svensson T.H. (2001) Effects of competitive and non-competitive NMDA receptor antagosnists on dopamine output in the shell and core subdivisions of the nucleus accumbens. Neuropharmacology, 40, 482-490.
96. Mark G.P., Weinberg, J.B., Rada, P.V., Hoebel, B.G. (1995) Extracellular acetylcholine is increased in the nucleus accumbens following the presentation of an aversively conditioned taste stimulus. Brain Res., 688, 184-188.
97. Matsumoto, R.R. (1989) GABA receptors: are cellular differences reflected in function? Brain Res. Brain Res. Rev., 14, 203-225.
98. Mauri, M.C., Ferrara, A., Boscati, L., Bravin,S., Zamberlan, F., Alecci, M., Invernizzi, G. (1998) Plasma and platelet amino acid concentrations in patients affected by major depression and under fluvoxamine treatment Neuropsychobiology, 37, 124-129.
99. Mayr, B., Montminy, M. (2001) Transcriptional regulation by the phosphorylation-dependent factor CREB. Nature Rev. Mol. Cell Biol., 2, 599-609.
100. McEwen, B.S., Angulo, J., Gould, E., Mendelson, S., Watanabe, Y. (1993) Antidepressant modulation of isolation and restraint stress effects on brain chemistry and morphology. Eur. Psychiatry, 8, (Suppl. 2), 41S-48S.
101. McLaughlin, J.P., Marton-Popovici, M., Chavkin, C. (2003) Kappa opioid receptor antagonism and prodynorphin gene disruption block stress-induced behavioral responses. J. Neurosci., 23, 5674-5683.
102. Meredith, G.E., Pennartz, C.M., Groenewegen, H.J. (1993) The cellular framework for chemical signalling in the nucleus accumbens. Prog. Brain Res., 99, 3-24.
103. Mifsud, J.C., Hernandez, L., Hoebel, B.G. (1989) Nicotine infused into the nucleus accumbens increases synaptic dopamine as measured by in vivo microdialysis. Brain Res., 478, 365-367.
104. Millan, M.J., Brocco, M., Papp, M., Serres, F., La Rochelle, C.D., Sharp, T., Peglion, J.L., Dekeyne, A. (2004) S32504, a novel naphtoxazine agonist at dopamine D3/D2 receptors: III. Actions in models of potential antidepressive and anxiolytic activity in comparison with ropinirole. J. Pharmacol. Exp. Ther., 309, 936-950.
105. Molina-Hernandez, M., Tellez-Alcantara, N.P., Garcia, J.P., Lopez, J.I.O., Jaramillo, M.T. (2005) Antidepressant-like actions of intra-accumbens infusions of allopregnanolone in ovariectomized Wistar rats. Pharmcol. Biochem. Behav., 80, 401-409.
106. Moreau, J.L., Scherschlicht, R., Jenck, F., Martin, J.R. (1995) Chronic mild stress-induced anhedonia model of depression; sleep abnormalities and curative effects of electroshock treatment. Behav. Pharmacol., 6, 682-687.
107. Morishima, Y., Miyakawa, T., Furuyashiki, T., Tanaka, Y., Mizuma, H., Nakanishi, S. (2005) Enhanced cocaine responsiveness and impaired motor coordination in metabotropic glutamate receptor subtype 2 knockout mice. Proc. Natl. Acad. Sci. USA, 102, 4170-4175.
108. Nakahara, D., Ozaki, N., Miura, Y., Miura, H., Nagatsu, T. (1989) Increased dopamine and serotonin metabolism in rat nucleus accumbens produced by hitracranial self-stimulation of medial forebrain bundle as measured by in vivo microdialysis. Brain Res., 495, 178-181.
109. Narita, M., Aoki, K., Takagi, M., Yajima, Y., Suzuki, T. (2003) Implication of brain-derived neurotrophic factor in the release of dopamine and dopamine-related behaviors induced by methamphetamine. Neuroscience, 119, 767-775.
110. Nestler, E.J., Barrot, M., DiLeone, R.J., Eisch, A. J., Gold, S.J., Monteggia, L.M. (2002) Neurobiology of depression. Neuron, 34, 13-25.
111. Newton, S.S., Thome, J., Wallace, T.L., Shirayama, Y., Schlesinger, L., Sakai, N., Chen, J., Neve, R., Nestler, E.J., Duman, R.S. (2002) Inhibition of cAMP response element-binding protein or dynorphin in the nucleus accumbens produces an antidepressant-like effect J. Neurosci., 22, 10883-16890.
112. Nibuya, M., Morinobu, S., Duman, R.S. (1995) Regulation of BDNF and trkB mRNA in rat brain by chronic electroconvulsive seizure and antidepressant drug treatments. J. Neurosci., 15, 7539-7547.
113. Nicola, S.M., Surmeier, J., Malenka, R.C. (2000) Dopaminergic modulation of neuronal excitability in the striatum and nucleus accumbens. Annu. Rev. Neurosci., 23, 185-215.
114. Nicola, S.M., Yun, I.A., Wakabayashi, K.T., Fields, H.L. (2004) Cue-evoked firing of nucleus accumbens neurons encodes motivational significance during a discriminative stimulus task. J. Neurophysiol., 91, 1840-1865.
115. Overstreet, D.H. (1986) Selective breeding for increased cholinergic function: development of a new animal model of depression. Biol. Psychiatry, 21, 49-58.
116. Overstreet, D.H., Pucilowski, O., Rezvani, A.H., Janowsky, D.S. (1995) Administration of antidepressants, diazepam and psychomotor stimulants further confirms the utility of Flinders Sensitive Line rats as an animal model of depression. Psychopharmacology, 121, 27-37.
117. Pandey, G.N., Dwivedi, Y., Ren, X., Rizavi, H.S., Mondal, A.C., Shukla, P.K., Conley, R.R. (2005) Brain region specific alterations in the protein and mRNA levels of protein kinase A subunits in the post-mortem brain of teenage suicide victims. Neuropsychropharmacology, 30, 1548-1556.
118. Papp, M., Klimek, V., Willner, P. (1994) Parallel changes in dopamine D2 receptor binding in limbic forebrain associated with chronic mild stress-induced anhedonia and its reversal by imipramine. Psychopharmacology, 115, 441-446.
119. Papp, M., Moryl, E. (1994) Antidepressant activity of non-competitive and competitive NMDA receptor antagonists in a chronic mild stress model of depression. Eur. J. Pharmacol., 263, 1-7.
120. Parsons, L.H., Justice, J.B. Jr. (1993) Perfusate serotonin increases extracellular dopamine in the nucleus accumbens as measured by in vivo microdialysis. Brain Res., 606, 195-199.
121. Paul, I.A., and Skolnick, P. (2003) Glutamate and depression. Ann. NY Acad. Sci., 1003, 250-272.
122. Paul, R.H., Brickman, A.M., Navia, B., Himkin, C., Malley, P.F., Jefferson, A.L., Cohen, R.A., Tate, D.F., Flanigan, T.P. (2005) Apathy is associated with volume of the nucleus accumbens in patients infected with HIV. J. Neuropsychiatry Clin. Neurosci., 17, 167-171.
123. Paulson, P.E., Camp, D.M., Robinson, T.E. (1991) Time course of transient behavioral depression and persistent behavioral sensitization in relation to regional brain monoamine concentrations during amphetamine withdrawal in rats. Psychopharmacology, 103, 480-492.
124. Pennartz, C.M., Dolleman-Van der Weel, M.J., Kitai, S.T., Lopes da Silva, F.H. (1992) Presynaptic dopamine D1 receptors attenuate excitatory and inhibitory limbic inputs to the shell region of the rat nucleus accumbens studied in vitro. J. Neurophysiol., 67, 1325-1334.
125. Pennartz, C.M., Groenewegen, H.J., Lopes da Silva, F.H. (1994) The nucleus accumbens as a complex of functionally distinct neuronal ensembles: an integration of behavioural, electrophysiological and anatomical data. Prog. Neurobiol., 42, 719-761.
126. Pennartz, C.M., Kitai, S.T. (1991) Hippocampal inputs to identified neurons in an in vitro slice preparation of the rat nucleus accumbens: evidence for feed-forward inhibition. J. Neurosci., 11, 2838-2847.
127. Petty, F. (1995) GABA and mood disorders: a brief review and hypothesis. J. Affect Disord., 34, 275-281.
128. Petty, F., Kramer, G.L., Gullion, C.M Rush, A.J. (1992) Low plasma, √ -aminobutyric acid levels in male patients with depression. Biol. Psychiatry, 32, 354-363.
129. Petty, F., Sherman, A.D. (1981) GABAergic modulation of learned helplessness. Pharmacol. Biochem. Behav., 15, 567-570.
130. Pierce, R.C., Bell, K., Duffy, P., Kalivas, P.W., (1996). Repeated cocaine augments excitatory amino acid transmission in the nucleus accumbens only in rats having developed behavioral sensitization. J. Neurosci., 16, 1550-1560.
131. Pliakas, A.M., Carlson, R.R., Neve, R.L., Konradi, C., Nestler, E.J., Carlezon, W.A. Jr. (2001) Altered responsiveness to cocaine and increased immobility in the forced swim test associated with elevated cAMP response element-binding protein expression in nucleus accumbens. J. Neurosci., 21. 7397-7403.
132. Popik, P., Kozela, E., Krawczyk, M. (2003) Nicotine and nicotinic receptor antagonists potentiate the antidepressant-like effects of imipramine and citalopram. Br. J, Pharmacol., 139, 1196-1202.
133. Rada, P.V., Mark, G.P., Hoebel, B.G. (1993) In vivo modulation of acetylcholine in the nucleus accumbens of freely moving rats: II. Inhibition by gamma-aminobutyric acid. Brain Res., 619, 105-110.
134. Rada, P., Moreno, S.A., Tucci, S., Gonzalez, L.E., Harrison, T., Chau, D.T., Hoebel, B.G., Hernandez, L. (2003) Glutamate release in the nucleus accumbens is involved in behavioral depression during the porsolt swim test. Neuroscience, 119, 557-565.
135. Rada, P., Pothos, E., Mark, G.P., Hoebel, B.G. (1991) Microdialysis evidence that acetylcholine in the nucleus accumbens is involved in morphine withdrawal and its treatment with clonidine. Brain Res., 561, 354-356.
136. Rahman, S., McBride, W.J. (2002) Involvement of GABA and cholinergic receptors in the nucleus accumbens on feedback control of somatodendritic dopamine release in the ventral tegmental area. J. Neurochem., 80, 646-654.
137. Romeo, E., Strohle, A., Spalletta, G., di Michele, F., Hermann, B., Holsboer, F., Pasini, A., Rupprecht, R. (1998) Effects of antidepressant treatment on neuroactive steroids in major depression. Am. J. Psychiatry, 155, 910-913.
138. Rossetti, Z.L., Lai, M., Hmaidan, Y., Gessa GL. (1993) Depletion of mesolimbic dopamine during behavioral despair: partial reversal by chronic imipramine. Eur. J. Pharmacol., 242, 313-315.
139. Roullet, P., Sargolini, F., Oliverio, A., Mele, A. (2001) NMDA and AMPA antagonist infusions into the ventral striatum impair differential steps of spatial information processing in a nonassociative task in mice. J. Neurosci., 21, 2143-2149.
140. Saito. Y., Cheng. M., Leslie. F.M., Civelti. O. (2001) Expression of the melanin-concentrating hormone (MCH) receptor mRNA in the rat brain. J. Comp. Neurol., 435, 26-40.
141. Saitoh, A., Kimura, Y., Suzuki, T., Kawai, K., Nagase, H., Kamei, J. (2004) Potential anxiolytic and antidepressant-like activities of SNC80, a selective delta-opioid agonist, in behavioral models in rodents. J. Pharmacol. Sci., 95, 374-380.
142. Sanacora, G., Rothman, D.L., Mason, G., Krystal, J.H. (2003) Clinical studies implementing glutamate neurotransmission in mood disorders. Ann. NY Acad. Sci., 1003, 292-308.
143. Scheggi, S., Leggio, B., Masi, F., Grappi, S., Gambarana, C., Nanni, G., Rauggi, R., De Montis, M.G. (2002) Selective modifications in the nucleus accumbens of dopamine synaptic transmission in rats exposed to chronic stress. J. Neurochem., 83, 895-903.
144. Semba, J., Mataki, C., Yamada, S., Nankai, M., Toru, M. (1998) Antidepressantlike effects of chronic nicotine on learned helplessness paradigm in rats. Biol. Psychiatry, 43, 389-391.
145. Shippenberg, T.S., Bals-Kubik, R., Herz, A. (1993) Examination of the neurochemical substrates mediating the motivational effects of opioids: role of the mesolimbic dopamine system and D-1 vs. D-2 dopamine receptors. J. Pharmacol. Exp. Ther., 265, 53-59.
146. Shirayama, Y., Chen, A. C., Nakagawa, S., Russell, D. S., Duman, R. S. (2002) Brain-derived neurotrophic factor produces antidepressant effects in behavioral models of depression. J. Neurosci., 22, 3251-3261.
147. Shirayama, Y., Ishida, H., Iwata, M., Hazama, G., Kawahara, R., Duman, R. S. (2004) Stress increases dynorphin immunoreactivity in limbic brain regions and dynorphin antagonism produces antidepressant-like effects. J. Neurochem., 90, 1258-1268.
148. Shytle, R.D., Silver, A.A., Lukas, RJ., Newman, M.B., Sheehan, D.V., Sanberg, P.R. (2002) Nicotinic acetylcholine receptors as targets for antidepressants. Mol. Psychiatry, 7, 525-535.
149. Shimizu, E., Hashimoto, K., Okamura, N., Koike, K., Komatsu, K., Kumakiri, C., Nakazato, M., Watanabe, H., Shinoda, N., Okada, S., Iyo,
150. Skolnick, P., (1999). Antidepressants for the new millenium. Eur. J. Pharmacol., 375, 31-40.
151. Skoublis, P.D., Lam, H.A., Shoblock, J., Narayanant, S., Maidment, N.T. (2005) Endogenous enkephalins, not endorphins, modulate basal hedonic state in mice. Eur. J. Neurosci., 21, 1379-1384.
152. Slemmer, J.E., Martin, B.R., Damaj, M.I. (2000) Bupropion is a nicotinic antagonist. J. Pharm. Exp.,Ther., 295, 321-327.
153. Smith, M.A., Makino, S., Kvetnansky. R, Post, R.M. (1995) Stress and glucocorticoids affect the expression of brain-derived neurotrophic factor and neurotrophin-3 mRNAs in the hippocampus. J. Neurosci., 15, 1768-1777.
154. Smith, Y., Kieval, J., Couceyro, P.R., Kuhar, M.J. (1999) CART peptide-immunoreactive neurones in the nucleus accumbens in monkeys: ultrastructural analysis, colocalization studies, and synaptic interactions with dopaminergic afferents. J. Comp. Neurol., 407, 491-511.
155. Smith, D.G., Tzavara, E.T., Shaw, J., Luecke, S., Wade, M., Davis, R., Salhoff, C., Nomikos, G.G., Gehlert, D.R. (2005) Mesolimbic dopamine super-sensitivity in melanin-concentrating hormone-1 receptor-deficient mice. J. Neurosci., 25, 914-922.
156. Smith-Roe, S.L., Sadeghian, K., Kelley, A.E. (1999) Spatial learning and performance in the radial maze is impaired after N-metyl-D-aspartate (NMDA) receptor blockade in striatal subregions. Behav. Neurosci., 113, 703-717.
157. Smith-Roe, S.L., Kelley, A.E. (2000) Coincident activation of NMDA and dopamine D1 receptors within the nucleus accumbens core is required for appetitive instrumental learning. J. Neurosci., 20, 7737-7742.
158. Spanagel, R., Herz, A., Shippenberg, T.S. (1990) The effects of opioid peptides on dopamine release in the nucleus accumbens: an in vivo microdialysis study. J. Neurochem., 55, 1734-1740.
159. Spanagel, R., Herz, A., Shippenberg, T.S. (1992) Opposing tonically active endogenous opioid systems modulate the mesolimbic dopaminergic pathway. Proc. Natl. Acad. Sci. USA, 89, 2046-2050.
160. Spooren, W.P., Gasparini, F., Salt, T.E., Kuhn, R. (2001) Novel allosteric antagonists shed light on mglu(5) receptors and CNS disorders. Trends Pharmacol. Sci., 22, 331-337.
161. Svingos, A.L., Colago, E.E., Pickel, V.M. (1999) Cellular sites for dynorphin activation of kappa-opioid receptors in the rat nucleus accumbens shell. J. Neurosci., 19, 1804-1813.
162. Tejedor-Real, P., Mico, J.A., Smadja, C., Maldonado, R., Roques, B.P., Gilbert-Rahola, J. (1998) Involvement of delta-opioid receptors in the effects induced by endogenous enkephalins on learned helplessness model. Eur. J. Pharmacol., 354, 1-7.
163. Tidey, J.W., Miczek, K.A. (1996) Social defeat stress selectively alters mesocurticolimbic dopamine release: an in vivo microdialysis study. Brain Res., 721, 140-149.
164. Todtenkopf, M.S., De Leon K.R., Stellar, J.R. (2000) Repeated cocaine treatment alters tyrosine hydroxylase in the rat nucleus accumbens. Brain Res. Bull., 52, 407-411.
165. Tran, A.H., Tamura, R., Uwano, T., Kobayashi, T., Katsuki, M., Ono, T. (2005) Dopamine D1 receptors involved in locomotor activity and accumbens neural responses to prediction of reward associated with place. Proc. Natl. Acad. Sci. USA, 102, 2117-2122.
166. Uzunova, V., Sheline, Y., Davis, J.M., Rasmusson, A., Uzunov, D.P., Costa, E., Guidotti, A. (1998) Increase in the cerebrospinal fluid content of neurosteroids in patients with unipolar major depression who are receiving fluoxetine or fluvoxamine. Proc. Natl. Acad Sci. USA, 95, 3239-3244.
167. Van Bockstaele, E.J., Chan, J., Pickel, V.M. (1996) Pre- and post-synaptic sites for serotonin modulation of GABA-containing neurons in the shell region of the rat nucleus accumbens. J. Comp. Neurol., 371, 116-128.
168. Van Bockstaele, E.J., Pickel, V.M. (1993) Ultrastructure of serotonin-immunoreactive terminals in the core and shell of the rat nucleus accumbens: cellular substrates for interactions with catecholamine afferents. J. Comp. Neurol., 334, 603-617.
169. Weiss, F., Markou, A., Lorang, M.T., Koob, G.F. (1992) Basal extracellular dopamine levels in the nucleus accumbens are decreased during cocaine withdrawal after unlimited-access self- administration. Brain Res., 593, 314-318.
170. Willner, P., Muscat, R., Papp, M. (1992) Chronic mild stress-induced anhedonia: a realistic animal model of depression. Neurosci. Biobebay Rev. 16, 525-534.
171. Willner, P., Lappas, S., Cheeta, S., Muscat, R. (1994) Reversal of stress-induced anhedonia by the dopamine receptor agonist, pramipexole. Psychopharmacology, 115, 454-462.
172. Xi, Z.-X., Ramamoorthy, S., Shen, H., Lake, R., Sannivel, D.J., Kalivas, P.W. (2003) GABA transmission in the nucleus accumbens is altered after withdrawal from repeated cocaine. J. Neurosci., 23, 3498-3505.
173. Yadid, G., Overstreet, D.H., Zangen, A. (2001) Limbic dopaminergic adaptation to a stressful stimulus in a rat model of depression. Brain Res., 896, 43-47.
174. Yan, Q.S. (2000) Activation of 5-HT2A/2C receptors within the nucleus accumbens increases local dopaminergic transmission. Brain Res. Bull., 51, 75-81.
175. Yang, S.C., Shieh, K.R. (2005) Differential effects of melanin concentrating hormone on the central dopaminergic neurons induced by the cocaine- and amphetamine-regulated transcript peptide. J. Neurochem., 92, 637-646.
176. Yun, I.A., Wakabayashi, K.T., Fields, H.L., Nicola, S.M., (2004) The ventral tegmental area is required for the behavioral and nucleus accumbens neuronal firing responses to incentive cues. J. Neurosci., 24, 2923-2933.
177. Zangen, A., Hyodo, K. (2002) Transcranial magnetic stimulation induces increases in extracellular levels of dopamine and glutamate in the nucleus accumbens. Neuroreport, 13, 2401-2405.
178. Zangen, A., Nakash, R., Overstreet, D.H., Yadid, G. (2001) Association between depressive behavior and absence of serotonin-dopamine interaction in the nucleus accumbens. Psychopharmacology 155, 434-439.
179. Zangen, A., Nakash, R., Yadid, G. (1999) Serotonin-mediated increases in the extracellular levels of beta-endorphin in the arcuate nucleus and nucleus accumbens: a microdialysis study. J. Neurochem., 73, 2569-2574.
180. Zangen, A., Overstreet DA., Yadid, G. (1997) High serotonin and 5-hydroxyindoleacetic acid levels in limbic brain regions in a rat model of depression: normalization by chronic antidepressant treatment. J. Neurochem., 69, 2477-2483.
181. Zung W.W. (1983) Review of placebo-controlled trials with bupropion. J. Clin. Psychiatry, 44, 104-114.